Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Number of holders
-
415
-
Total 13F shares, excl. options
-
494,500,315
-
Shares change
-
-65,417,267
-
Total reported value, excl. options
-
$3,725,733,619
-
Value change
-
-$615,772,920
-
Put/Call ratio
-
76%
-
Number of buys
-
171
-
Number of sells
-
-196
-
Price
-
$7.53
Significant Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2023
521 filings reported holding TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share as of Q2 2023.
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) has 415 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 494,500,315 shares
of 1,147,663,152 outstanding shares and own 43% of the company stock.
Largest 10 shareholders include BlackRock Inc. (40,289,807 shares), Phoenix Holdings Ltd. (33,703,410 shares), Ion Asset Management Ltd. (33,063,004 shares), Clal Insurance Enterprises Holdings Ltd (31,614,669 shares), MENORA MIVTACHIM HOLDINGS LTD. (26,578,560 shares), Lingotto Investment Management LLP (24,213,261 shares), Migdal Insurance & Financial Holdings Ltd. (23,646,440 shares), Rubric Capital Management LP (18,718,362 shares), STATE STREET CORP (15,573,344 shares), and MILLENNIUM MANAGEMENT LLC (14,030,069 shares).
This table shows the top 415 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.